共 50 条
- [1] Cost-effectiveness of antiplatelet agents in secondary stroke prevention: The limits of certainty[J]. VALUE IN HEALTH, 2005, 8 (05) : 572 - 580Matchar, DBSamsa, GPLiu, S
- [2] Cost-effectiveness of antiplatelet agents in secondary stroke prevention: The limits of certainty[J]. NEUROLOGY, 2004, 62 (07) : A466 - A466Matchar, DBSamsa, GPLiu, SP
- [3] Antiplatelet Agents' Effectiveness for Secondary Prevention of Ischemic Stroke[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S218 - S218Kim, Mi-SookKim, Ye-JeeSeong, Jong-MiChoi, Nam-KyongPark, Byung-Joo
- [4] Antiplatelet agents for secondary prevention of stroke[J]. Current Treatment Options in Cardiovascular Medicine, 2008, 10 (3) : 223 - 228Bernstein R.A.
- [5] ANTIPLATELET AGENTS AND SECONDARY STROKE PREVENTION[J]. TGO-TIJDSCHRIFT VOOR THERAPIE GENEESMIDDEL EN ONDERZOEK JDR-JOURNAL FOR DRUGTHERAPY AND RESEARCH, 1991, 16 (04): : 105 - 114KEYSER, A
- [6] Antiplatelet agents in secondary prevention of stroke - A perspective[J]. STROKE, 2005, 36 (09) : 2034 - 2036Norris, JW
- [7] Antiplatelet agents for secondary prevention of ischemic stroke[J]. ANNALS OF PHARMACOTHERAPY, 2001, 35 (10) : 1241 - 1247Majid, ADelanty, NKantor, J
- [8] Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectiveness[J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2015, 4 (04) : 377 - 384Rothlisberger, Julia M.Ovbiagele, Bruce
- [9] Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack[J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (18) : 2773 - 2778Sarasin, FPGaspoz, JMBounameaux, H
- [10] Combination antiplatelet agents for secondary prevention of ischemic stroke[J]. PHARMACOTHERAPY, 2008, 28 (10): : 1233 - 1242Griend, Joseph P. VandeSaseen, Joseph J.